Virax Biolabs Group Limited
Q3 2024 13F Holders
Symbol
VRAX
CUSIP
G9495L125
Type
Equity
Class
SHS NEW
Num filings
6
Total reported value, excl. options
$424 k
Compare 2024 Q3 to
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q2
2024 Q1
2023 Q4
Manager
Report Date
Value ($000)
Shares
Option Type